A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f and Luveris Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique.

Trial Profile

A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f and Luveris Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Follitropin alfa (Primary) ; Lutropin alfa (Primary)
  • Indications Infertility
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck KGaA
  • Most Recent Events

    • 12 May 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to discontinued.
    • 12 Feb 2013 Planned End Date changed from 1 Aug 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 08 Jun 2012 Planned End Date changed from 1 Feb 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top